SEC Form 4 · accession 0001455244-17-000033

ChronoScale Holdings Corp · CHRN

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Officer — Chief Financial Officer

Period of report

Aug 31, 2017

Accepted (ET)

Sep 5, 2017 · 6:19 pm EDT

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0001549084

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I	Nature of ownership
Common Stock^F1,F2	Aug 31, 2017	X	12,554	$1.00	D	22,371	D

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
Subscription Rights (right to buy)	$1.00	Aug 31, 2017	X	9,817	D	Aug 10, 2017	Aug 31, 2017	Common Stock	12,554	0	D

F1On August 14, 2017, Ekso Bionics Holdings, Inc. (the "Company") issued a press release announcing the commencement of a pro rata offering (the "Rights Offering") of rights to holders of the Company's common stock and certain holders of warrants issued by the Company, as of the record date of August 10, 2017, to subscribe for up to an aggregate of 34,000,000 shares of common stock. Each subscription right included a basic subscription right, which entitled its holder to purchase 1.1608 shares of common stock at a subscription price of $1.00, and an over-subscription right, which entitled its holder to purchase up to 1.1608 shares of common stock at a subscription price of $1.00, subject to the availability and pro rata allocation of shares among rights holders exercising their over-subscription rights.
F2The reporting person exercised in full his basic subscription rights, pursuant to which he acquired 11,394 shares of common stock. The reporting person also exercised 1,000 of his over-subscription rights for an additional 1,160 shares of common stock.